Virginie Delwart

Director, Patient Advocacy
Regeneron Pharmaceuticals, Inc.
Tarrytown, New York, United States

Presentation(s):

• PB0500 - Communicating gene editing in hemophilia: development of a universal lexicon

  Monday, June 24, 2024
  13:45 – 14:45 ICT